TrustCore Financial Services’s Genmab GMAB Stock Holding History

TrustCore Financial Services’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$7.67K	Hold	181	–	–	﹤0.01%	761
2022 Q3	$6K	Hold	181	–	–	﹤0.01%	839
2022 Q2	$6K	Hold	181	–	–	﹤0.01%	819
2022 Q1	$7K	Buy	181 +130	+255%	+$4.46K	﹤0.01%	809
2021 Q4	$2K	Sell	51 -130	-72%	-$5.42K	﹤0.01%	870
2021 Q3	$8K	Hold	181	–	–	﹤0.01%	796
2021 Q2	$7K	Hold	181	–	–	﹤0.01%	793
2021 Q1	$6K	Sell	181 -201	-53%	-$7.56K	﹤0.01%	762
2020 Q4	$16K	Buy	+382	New	+$14.3K	﹤0.01%	601

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TrustCore Financial Services's GMAB Position: Q4 2022 in Review

TrustCore Financial Services held its Genmab (GMAB) position steady in Q4 2022 at 181 shares worth $7.67K. The position accounts for ﹤0.01% of the portfolio, ranked #761.

TrustCore Financial Services first reported a position in GMAB in Q4 2020 and has held it in 9 quarters since. The position peaked at $16K in Q4 2020. 237 funds tracked by Wall St. Rank hold GMAB as of Q4 2022.

TrustCore Financial Services held 181 shares of Genmab worth $7.67K as of Q4 2022.
TrustCore Financial Services left its Genmab share count unchanged in Q4 2022.
Genmab made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #761 holding.
TrustCore Financial Services first reported a position in Genmab in Q4 2020 and has held it in 9 quarters since.
TrustCore Financial Services's Genmab position peaked at $16K in Q4 2020.
237 funds tracked by Wall St. Rank held Genmab as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.